Presepsin as a predictor of positive blood culture in suspected neonatal sepsis

Presepsin as a predictor of positive blood culture in suspected neonatal sepsis Neonatal sepsis is the most common cause of morbidity and mortality during the neonatal period. Neonatal sepsis is classified as either early‐onset sepsis (EOS; ≤7 days after birth) or late‐onset sepsis (LOS; >7 days after birth). Advances in obstetric and neonatal care have decreased the incidence of neonatal sepsis, especially EOS. Currently, the incidence of group B Streptococcus‐specific EOS has declined to 0.3–0.4 cases/1,000 live births, and overall the EOS incidence has declined to 0.8–1.0 cases/1,000 live births. Nevertheless, EOS remains a severe life‐threatening disease with a mortality rate ranging from 1.5% in term infants to almost 40% in very low‐birthweight infants. Early diagnosis and treatment of neonatal sepsis are important to prevent severe complications. In this era of multi‐resistant microorganisms, however, it is also important to avoid the unnecessary use of antibiotics in sepsis‐negative infants. On the basis of the Centers for Disease Control and Prevention 2010 guidelines, Escobar et al. reported that, in a cohort of 7,004 infants, 13% of both well‐appearing and ill‐appearing infants were evaluated for EOS, and 11% were treated empirically with antibiotics, although only 0.04% of the cohort had blood culture‐confirmed infection. Concern has arisen regarding the EOS results and the empirical antibiotic treatment of hundreds http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Pediatrics International Wiley

Presepsin as a predictor of positive blood culture in suspected neonatal sepsis

Loading next page...
 
/lp/wiley/presepsin-as-a-predictor-of-positive-blood-culture-in-suspected-IZzMYP2Y2D
Publisher
Wiley
Copyright
Copyright © 2018 Japan Pediatric Society
ISSN
1328-8067
eISSN
1442-200X
D.O.I.
10.1111/ped.13469
Publisher site
See Article on Publisher Site

Abstract

Neonatal sepsis is the most common cause of morbidity and mortality during the neonatal period. Neonatal sepsis is classified as either early‐onset sepsis (EOS; ≤7 days after birth) or late‐onset sepsis (LOS; >7 days after birth). Advances in obstetric and neonatal care have decreased the incidence of neonatal sepsis, especially EOS. Currently, the incidence of group B Streptococcus‐specific EOS has declined to 0.3–0.4 cases/1,000 live births, and overall the EOS incidence has declined to 0.8–1.0 cases/1,000 live births. Nevertheless, EOS remains a severe life‐threatening disease with a mortality rate ranging from 1.5% in term infants to almost 40% in very low‐birthweight infants. Early diagnosis and treatment of neonatal sepsis are important to prevent severe complications. In this era of multi‐resistant microorganisms, however, it is also important to avoid the unnecessary use of antibiotics in sepsis‐negative infants. On the basis of the Centers for Disease Control and Prevention 2010 guidelines, Escobar et al. reported that, in a cohort of 7,004 infants, 13% of both well‐appearing and ill‐appearing infants were evaluated for EOS, and 11% were treated empirically with antibiotics, although only 0.04% of the cohort had blood culture‐confirmed infection. Concern has arisen regarding the EOS results and the empirical antibiotic treatment of hundreds

Journal

Pediatrics InternationalWiley

Published: Jan 1, 2018

Keywords: ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off